Bicara Therapeutics Inc. · NASDAQ:BCAX

Cohlhepp Ryan sold 12,500 Bicara Therapeutics Inc. shares (Form 4)

Traded May 15, 2026 · Filed May 18, 2026

On May 15, 2026, Cohlhepp Ryan (Director, President and COO) sold 12,500 Bicara Therapeutics Inc. shares at US$20.29 for US$254K under a trading plan, leaving 191,641 shares. Filed May 18, 2026 (Form 4).

Sold
12,500 shares
Price
US$20.29
Value
US$254K
Holding after
191,641 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, President and COO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 15, 2026Common StockOption exercise8,000US$3.79204,141Direct
May 15, 2026Common StockSale8,000US$20.29196,141Direct
May 15, 2026Common StockSale4,500US$20.29191,641Direct

Source

View original at SEC

Related